Aya Salman, Sherif S Abdel Mageed, Doaa Fathi, Mahmoud A Elrebehy, Ahmed I Abulsoud, Shereen Saeid Elshaer, Emad Gamil Khidr, Tohada M Al-Noshokaty, Reem Khaled, Nehal I Rizk, Mohammed S Elballal, Ghadir A Sayed, Mai A Abd-Elmawla, Manar Mohammed El Tabaa, Osama A Mohammed, Alaa Ashraf, Ahmed A El-Husseiny, Heba M Midan, Walaa A El-Dakroury, Mustafa Ahmed Abdel-Reheim, Ahmed S Doghish
Malignant pleural mesothelioma (MPM) is a highly invasive form of lung cancer that adversely affects the pleural and other linings of the lungs. MPM is a very aggressive tumor that often has an advanced stage at diagnosis and a bad prognosis (between 7 and 12 months). When people who have been exposed to asbestos experience pleural effusion and pain that is not explained, MPM should be suspected. After being diagnosed, most MPM patients have a one- to four-year life expectancy. The life expectancy is approximately six months without treatment...
November 13, 2023: Pathology, Research and Practice